ASCT RESPONDS TO PROFICIENCY TESTING PROPOSED RULE
The ASCT presented two documents to the Centers for Medicare & Medicaid Services (CMS) in response to the Notice of Proposed Rule Making (NPRM) for the “Proposals to Improve Cytology Proficiency Testing Required by the Clinical Laboratory Improvement Amendments of 1988".
The first document is the ASCT organizational response, which is represented by a summary of the ASCT membership responses that were gathered using a web-based survey sponsored by the ASCT. To view a PDF of this document, click here.
In keeping with the mission of the ASCT to be the collective voice of our profession, the ASCT also offered cytotechnologists who are not members of the ASCT the opportunity to participate in our web-based survey regarding this NPRM. These responses were also submitted to the CMS in a document containing the survey question results and summary of comments from all respondents (members and non-members). To view a PDF of this document, click here.
The ASCT is proud to represent our members’ position on legislative and regulatory issues, and to support the practice of all cytotechnologists.
AMERICAN SOCIETY FOR CYTOTECHNOLOGY MISSION STATEMENT
The American Society for Cytotechnology (ASCT), as the collective voice for the profession, is committed to defining and promoting cytotechnology by:
- Developing practice standards.
- Monitoring and evaluating
legislative/regulatory issues and emerging technologies
affecting the profession; and
- Providing unique, practical educational opportunities pertinent to the practice of cytotechnology.
